Presenting Weight Loss Treatment as Positive Opportunity Is Beneficial
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 7, 2023 -- For patients with obesity seeing a general practitioner, presenting weight loss treatment as a positive opportunity is associated with increased uptake of treatment and more weight loss, according to a study published online Nov. 7 in the Annals of Internal Medicine.
Charlotte Albury, D.Phil., from the University of Oxford in the United Kingdom, and colleagues examined the relationships between language used in the clinical visit and patient weight loss in a mixed-methods cohort study conducted at 38 primary care clinics in England. A total of 246 patients with obesity seen by 87 general practitioners randomly sampled from the intervention group of a clinical trial were included in the study; conversational analysis of recorded discussions regarding referral to a behavioral weight management program was conducted.
The researchers identified three interactional approaches based on clinicians' linguistic and paralinguistic practices: creating a sense of referrals as "good news" related to the opportunity of referral; "bad news" focusing on the harms of obesity; or neutral (62, 82, and 102, respectively). Good news was associated with increased agreement to attend the program and increased attendance (adjusted risk differences, 0.25 and 0.45, respectively), as well as weight change (adjusted difference, −3.60 kg), relative to neutral news. Comparing bad and neutral news, there was no evidence of differences in mean weight change; patient satisfaction did not differ across the three approaches.
"Patients have reported that clinicians' words and tone matter to them and can motivate or demotivate weight loss," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
WEDNESDAY, May 22, 2024 -- For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research...
Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children
WEDNESDAY, May 22, 2024 -- High ultraprocessed food (UPF) consumption in young children is associated with adiposity and other cardiometabolic risk factors, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.